Baylor St. Luke's Medical Center
   Execute Search
Research Services

New Search

Clinical Trials
(Study Profile Page)

Study 1 of 1 for search of: Protocol Number - HSC-MS-10-0533

Previous  Previous Study Return to Search Form Next Study  Next

Hypertrophy Regression with N-Acetylcysteine in Hypertrophic Cardiomyopathy

Protocol #: HSC-MS-10-0533 Account #: B216

This study is currently RECRUITING.  

Sponsored by: NIH 
Principal Investigator: Ali Marian M.D. 
SLEH Estimated Enrollment: 75 

Condition Intervention Intervention Detail Phase
Hypertrophic Cardiomyopathy  DRUG  Drug: N-acetylcysteine (NAC)  


Objective & Purpose:
The purpose of the sudy is to conduct a small study to gather the preliminary data for future large scale clinical studies that will be designed to test the potential beneficial efffect of over-the counter study anti-oxidant drug called N-acetylcysteine (NAC) in patients with a heart muscle condition called Hypertrophic Cardiomyopathy (HCM). The present study is a pilot feasibility study, the investigators want to find out whether the investigators can recruit and retain patients with HCM in the study and whether these patients can tolerate this drug and can stay on for one year. Likewise, the investigators want to find out any potential side effects that this drug might have and estimate whether it has any beneficial effects.


Please refer to this study by its IRB#:     HSC-MS-10-0533     

Contact: Yanli Tan 

Anita Deswal, M.D.
Benjamin Cheong, M.D.


Key Words:
 Identifier:       NCT01537926     

Direct link to this page:  
OR paste this link into an email or document: